diabetic kidney disease
Advertisement
SC0062 met the 12-week primary end point of a reduction in proteinuria in a study cohort with diabetic kidney disease (DKD).
Using NURTuRE-CKD data, researchers studied kidney outcomes and heterogeneity of risk by primary renal diagnosis.
Monlunabant failed in a study of its use in DKD, but Novo Nordisk had positive news about other kidney treatments in 2024.
A study examined the efficacy of adding SZC to allow patients with stage 3-4 DKD to maintain treatment with RAASi.
Researchers tried to determine whether eGFR slope is a predictor of type 2 diabetes complications.
A study examined the association of HbA1c with mortality in patients with chronic kidney disease and type 2 diabetes.
Researchers assessed the landscape of QSP modeling and developed a use case for QSP to determine hyperkalemia risk.
The four-pillar approach to treating diabetic kidney disease (DKD) has been endorsed by high-quality trials, such as FLOW.
Ajay K. Singh discussed his findings on daprodustat dosing and utilization of finerenone.
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
The most common primary renal disease in patients initiating renal replacement therapy is diabetes.
Several classes of glucose-lowering drugs have been shown to have kidney benefits in patients with type 2 diabetes.
The most common concomitant medication classes were antihypertensives (95%), antihyperglycemic (81%), and statins (79%).
Preliminary evidence has demonstrated preservation of kidney function as measured by eGFR compared with baseline.
There was a five-fold higher risk of hyperkalemia with use of a steroidal MRA plus an ACEi or ARB.
Assessing the early impact of risk categorization on management of patients with DKD.
Gaps in care in treating proteinuria in patients with DKD.
In the population of patients with chronic kidney disease (CKD), particularly those with diabetes as the underlying ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.